STAT News

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.

Por STAT News

1 minuto de lectura
Compartir
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas